Skip to main navigation Skip to search Skip to main content

Combination Trial of Duvelisib (IPI-145) with Bendamustine, Rituximab, or Bendamustine/Rituximab in Patients with Lymphoma or Chronic Lymphocytic Leukemia

  • Ian W. Flinn
  • , Mohamad Cherry
  • , Mohamad Cherry
  • , Michael Maris
  • , Jeffrey V. Matous
  • , Jesus G. Berdeja
  • , Manish R. Patel
  • Sarah Cannon Research Institute
  • University of Oklahoma

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume126
Issue number23
DOIs
StatePublished - Dec 3 2015
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Gastroenterology
  • Surgery
  • Internal Medicine

Cite this